drugset / Trial / NCT00469300

Iontophoretic Application of Acyclovir Gel to Treat Cold Sores

NCT00469300

Phase 2 Completed 810 enrolled Transport Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the sites where the herpes virus is replicating. Iontophoresis uses electric current to enhance delivery of drugs through the skin. This trial is testing a new iontophoretic device with a new acyclovir gel to treat cold sores.

Timeline

Start
2007-04
Primary completion
2007-09
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Acyclovir Small molecule 5 % Topical

Indications